Everyone loses hair, every single day. We see strands everywhere – the shower, in the brush, on our pillows. Thinning in women usually means a reduction in volume as well as less physical hairs on our head. As strands diminish in number, there is a lack of density.
The American Hair Loss Association estimates that women make up roughly 40 percent of Americans experiencing thinning hair and the majority of women will experience some thinning by midlife – putting it right up with weight gain, dry skin and wrinkles.
It is completely natural for hair to thin over time. According to the American Academy of Dermatology, we normally shed about 100 hairs a day. So, while 85-to-95 percent of the hair on your head is growing, the other 5-to-15 percent is in a resting stage. After “resting,” this hair falls out — often while you’re brushing or shampooing it — and is replaced by new growth.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7361651-biota-botanicals-age-related-thinning-hair-care-for-women/
Virginia Bioinformatics Institute (VBI), a world-class research institute dedicated to the study of information biology, is using DataDirect Networks (DDN) SFA® high-performance storage engine-based GRIDScaler GPFS parallel file system to perform rapid, accurate Ebola outbreak modeling for the U.S. Department of Defense’s Defense Threat Reduction Agency (DTRA).
A team of 30 researchers and scientists on VBI’s Ebola rapid response team initially provided DTRA and West Africa’s Ministries of Health (MOH) with short-term forecasts on vaccine production and disease spread.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7429756-ddn-gridscaler-vbi-ebola/
The American Society for Aesthetic Plastic Surgery (ASAPS) released its complete 18th annual multi-specialty statistical data today showing an aesthetic plastic surgery spend consistent with the figures for 2013, with Americans spending more than 12 billion dollars on surgical and nonsurgical procedures for the second year in a row. With more than 10 million cosmetic procedures performed in 2014, those that showed the largest growth in volume on a year-over-year basis included buttock augmentation (up 86%), labiaplasty (up 49%), and nonsurgical fat reduction (up 42%). Additionally, more men are turning to aesthetic cosmetic procedures, with dramatic increases seen in both surgical and nonsurgical options over the past 5 years and a 43% increase overall.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7310751-asaps-2014-plastic-surgery-trends/
Top Hybrids and Electric Cars Must Buy 2016 [ Buying Guide ]
Top Recommended Hybrids and Electric Cars
List Car you need to buy:
====== 2016 Tesla Model S ========
We owned a 2013 Tesla Model S for 18 months and despite numerous dealer visits and maintenance issues, we were ultimately sad to see it go. It's quick, comfortable, quiet, spacious, and can tote as much cargo as some crossover SUVs. The "85" version can go 265 miles on a charge, so range anxiety is a nonissue. We even drove ours from L.A. to New York in less than three days using Tesla's free Supercharger quick-charge network. We definitely have gripes, including some underwhelming interior trim pieces and a lack of small item storage. There's also the below-average reliability, although our dealer experiences were exceptional. So even though it's not perfect, the Model S remains our favorite electric car.
============2016 Kia Soul EV============
Kia's first real foray into the electric vehicle world is a success. In fact, the funky Soul is arguably more appealing when it swaps out its internal combustion engine for an electric motor. In our testing, the Soul EV went farther on a charge than its similarly sized and priced competitors, and then recharged quickly thereafter. It also doesn't suffer a reduction in cargo space versus the non-EV Soul, meaning it provides the utility of a small SUV rather than that of a small hatchback like its rivals. A long warranty and generous features are other benefits.
===============2015 BMW i3=============
BMW's i3 is a remarkable vehicle. Its main structure is made of light yet strong carbon fiber instead of the usual steel or aluminum. This helps reduce the i3's weight, which pays dividends for both electric range and performance. With its electric motor in back and the battery under the floor, the i3 boasts sporty acceleration and handling.
======= 2015 BMW i8 ===========
You want your plug-in hybrid to be a head-turning sports car? Look no further than the BMW i8, the two-door supercar for the environmentally conscious. Like the more attainable BMW i3, the i8 is built around a carbon-fiber passenger cell. But in the i8 an electric motor drives the front wheels and a turbocharged three-cylinder gasoline engine pushes from behind.
===== Luxury Hybrid 2016 Porsche Panamera E-Hybrid =====
Porsche's flagship sedan is the Panamera, a low-slung four-door with a hatchback trunk. The 2016 Porsche Panamera S E-Hybrid is the plug-in hybrid version, and it offers 16 miles of pure electric driving before the supercharged 3.0-liter gasoline V6 engine takes over. Acceleration, handling and braking are pure Porsche, which is something of a trick for a car this large. It's perfect for those shoppers
======= Hybrid SUV 2016 Toyota Highlander Hybrid =========
No other automaker bothers to offer a hybrid version of its three-row SUV. But Toyota's Highlander Hybrid doesn't earn a spot in our Buying Guide purely by default. It continues to show just how well the hybrid formula can be applied to a big, family-friendly crossover SUV. The hybrid version earns a 28 mpg combined estimate, or 7-8 mpg better than the V6-powered Highlander. In addition to that, the Highlander Hybrid offers solid build quality, respectable acceleration, a sophisticated and quiet ride quality and plenty of standard and available features.
====== 2016 Toyota Camry Hybrid 2016 Toyota Prius =====
Substantial changes last year vaulted the Toyota Camry Hybrid onto our top-recommended list. Although it doesn't quite match the fuel economy of some competitors, the real-world cost of that difference is negligible. Plus, dismissing the Camry simply because of an mpg or two would mean missing out on an otherwise compelling sedan. Comfort remains a Camry priority, but this latest Camry Hybrid also handles pretty well.
====== Hybrid Cars 2016 Ford Fusion Hybrid / Energi =====
The 2016 Ford Fusion Hybrid is a great choice for car shoppers who are new to hybrids. It's quiet, comfortable and feels very much like a normal family sedan, while delivering the fuel economy you expect from a hybrid. It's also a Ford Fusion, which means you also get impressive refinement, good road manners and plenty of standard and available high-tech features.
======= 2016 Volkswagen e-Golf =====
Among entry-level EVs, the Volkswagen e-Golf is our favorite. It handles well, has a handsome interior, delivers class-competitive range and has the optimal equipment for quick battery recharging. What's even better, cargo space is unchanged from the non-EV Golf because the batteries are located under the floor.
With 830 women dying every day from preventable causes related to pregnancy and childbirth, and over 16,000 children under age five dying daily, Bayer and the White Ribbon Alliance today released critical policy recommendations and launched community programs to support the reduction and prevention of maternal, newborn and child mortality in two developing countries.1,2
Established through a three-year $1.3 million commitment from Bayer, these programs will expand work conducted by White Ribbon Alliance in Bangladesh and Zimbabwe to support the United Nations Secretary General’s Every Woman Every Child movement.
This announcement comes at the one-year anniversary of the Bayer/White Ribbon Alliance commitment in support of the Every Woman Every Child movement and will contribute to the success of the Sustainable Development Goals.
To view the multimedia release go to:
http://www.multivu.com/players/English/77126510-bayer-white-ribbon-alliance-self-care/
A ten-month clinical trial at Sentara Leigh Hospital in Norfolk, Virginia has determined that hard surfaces and linens infused with copper oxide compounds contributed to an 83% reduction in C-difficile and a 78% overall reduction in a host of multi-drug resistant organisms (MDROs) including C-diff, MRSA and VRE in a real-world clinical environment. These results occurred in a hospital with a robust protocol for managing infection risk certified by the health care accrediting body DNV-GL Healthcare.
The results of the trial were published in the peer-reviewed American Journal of Infection Control on Sept. 28, 2016 and will be presented at the annual conference of the Infectious Disease Society of America in New Orleans, Louisiana on October 27, 2016.
To view the multimedia release go to:
http://www.multivu.com/players/English/7955751-sentara-healthcare-infections-copper-clinical-trial/
A ten-month clinical trial at Sentara Leigh Hospital in Norfolk, Virginia has determined that hard surfaces and linens infused with copper oxide compounds contributed to an 83% reduction in C-difficile and a 78% overall reduction in a host of multi-drug resistant organisms (MDROs) including C-diff, MRSA and VRE in a real-world clinical environment. These results occurred in a hospital with a robust protocol for managing infection risk certified by the health care accrediting body DNV-GL Healthcare.
The results of the trial were published in the peer-reviewed American Journal of Infection Control on Sept. 28, 2016 and will be presented at the annual conference of the Infectious Disease Society of America in New Orleans, Louisiana on October 27, 2016.
To view the multimedia release go to:
http://www.multivu.com/players/English/7955751-sentara-healthcare-infections-copper-clinical-trial/
Global biotherapeutics leader CSL Behring today announced that results were published in the New England Journal of Medicine (NEJM) from the COMPACT study, a pivotal Phase III study evaluating the safety and efficacy of CSL830 (a novel, investigational, self-administered, subcutaneous C1-Esterase Inhibitor [C1-INH] Human replacement therapy) for the prevention of HAE attacks. The study met its primary efficacy endpoint, significantly reducing the time-normalized number of HAE attacks. In addition, the study met its secondary endpoints, including the responder rate (patients who had at least a 50% reduction in their attack rate) and the number of rescue medication uses. If approved by the FDA, CSL830 would be the first and only subcutaneous preventative therapy for HAE.
To view the multimedia release go to:
https://www.multivu.com/players/English/8056151-csl-behring-subcutaneous-c1-esterase-inhibitor-hae-patients/
